Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2020
Cabotegravir Plus Rilpivirine: First Approval.
A Markham
PubMed ↗
Publisher ↗
No numbers read from the abstract.
28 papers cite it
2020
2021
2022
2023
2024
2025
this paper
cites it
Cabotegravir Plus Rilpivirine: First Approval. | OpenQuestion